Neuland Laboratories Limited (NSE:NEULANDLAB)

Neuland Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	875.75	454.16	50.91	24.36	112.04
Short-Term Investments	-	-	33.77	64.56	75
Cash & Short-Term Investments	875.75	454.16	84.68	88.91	187.04
Cash Growth	92.83%	436.31%	-4.76%	-52.46%	21.15%
Accounts Receivable	3,760	3,687	2,380	2,207	1,920
Other Receivables	70.45	31.6	35.16	16.66	84.66
Receivables	3,830	3,719	2,415	2,223	2,005
Inventory	3,504	2,792	2,652	2,476	2,195
Prepaid Expenses	111.41	105.38	74.16	71.75	60.83
Other Current Assets	889.07	538.4	582.18	635.87	703.83
Total Current Assets	9,211	7,609	5,808	5,496	5,152
Property, Plant & Equipment	5,686	4,980	4,866	4,312	3,651
Long-Term Investments	12.79	5.25	4.97	4.4	36.57
Goodwill	2,795	2,795	2,795	2,795	2,795
Other Intangible Assets	24.58	13.01	21.2	34.98	19.58
Other Long-Term Assets	596.7	395.86	340.41	605.74	656.26
Total Assets	18,326	15,798	13,835	13,248	12,310
Accounts Payable	1,920	1,710	1,174	1,521	1,156
Accrued Expenses	1,060	626.39	451.21	480.95	272.44
Short-Term Debt	-	111.58	922.15	569.84	1,682
Current Portion of Long-Term Debt	375.86	361.07	344.84	250.58	140.45
Current Portion of Leases	36.79	30.92	26.46	25.32	15.66
Current Income Taxes Payable	0.81	104.02	-	-	-
Other Current Liabilities	883.53	1,446	713.08	837.07	310.42
Total Current Liabilities	4,277	4,390	3,632	3,685	3,576
Long-Term Debt	449.21	742.46	1,042	881.33	773.73
Long-Term Leases	92.03	38.48	69.4	95.86	25.78
Long-Term Unearned Revenue	-	-	-	0.3	202.8
Long-Term Deferred Tax Liabilities	604.39	582.99	566.99	597.57	477.81
Other Long-Term Liabilities	39.56	33.11	32.52	54.53	51.07
Total Liabilities	5,499	5,857	5,430	5,383	5,210
Common Stock	128.3	128.3	128.3	128.3	128.3
Additional Paid-In Capital	4,978	4,978	4,978	4,978	4,978
Retained Earnings	7,804	4,931	3,360	2,761	1,980
Comprehensive Income & Other	-82.79	-96.38	-61.31	-2.01	13.64
Total Common Equity	12,827	9,941	8,405	7,865	7,100
Shareholders' Equity	12,827	9,941	8,405	7,865	7,100
Total Liabilities & Equity	18,326	15,798	13,835	13,248	12,310
Total Debt	953.9	1,284	2,405	1,823	2,637
Net Cash (Debt)	-78.14	-830.34	-2,321	-1,734	-2,450
Net Cash Per Share	-6.09	-64.72	-180.88	-135.15	-190.98
Filing Date Shares Outstanding	12.83	12.83	12.83	12.83	12.83
Total Common Shares Outstanding	12.83	12.83	12.83	12.83	12.83
Working Capital	4,934	3,219	2,176	1,811	1,576
Book Value Per Share	999.78	774.83	655.11	612.99	553.36
Tangible Book Value	10,008	7,133	5,589	5,035	4,285
Tangible Book Value Per Share	780.04	555.99	435.64	392.44	334.02
Land	287.48	107.43	107.43	107.43	107.43
Buildings	2,049	1,820	1,722	1,375	1,205
Machinery	5,336	4,635	4,337	3,754	2,945
Construction In Progress	458.91	405.66	204.57	172.5	237.51

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.